אוויסטה - Evista
ש××× ×× !
×ת×ר××: 26/01/2025 ×תק××× ××××¢× ×× ×©××××§ ×תר××¤× ××פסק ×צ××ת×ת.
×ת×ר××: 26/01/2025 ×תק××× ××××¢× ×× ×©××××§ ×תר××¤× ××פסק ×צ××ת×ת.
××§×ר: ××©×¨× ××ר×××ת - ××××¢×ת ×¢× ×פסקת ש××××§ תר×פ×ת
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | G03XC Selective estrogen receptor modulators | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||
| צ×רת ××ª× | פ××× - PER OS | ||||||||||||||||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||
| ×ת×××× | Evista is indicated for the treatment of osteoporosis in post menopausal women. Evista is indicated for the prevention of osteoporosis in post menopausal women . Evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. Evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
| ||||||||||||||||||
| |||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ××××ס×× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | LILLY S.A., SPAIN |
| ×©× ××¢× ×ר×ש×× | ELI LILLY ISRAEL LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 12/2003. ר×ש××× ×ת×ר××: 12/2013 |
| ת×ר×× ×¢×××× ××ר×× | 26/01/2025 |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־8 בפברואר 2025 ב־15:57